Goal-Setting in Multiple Sclerosis-Related Spasticity Treated with Botulinum Toxin: The GASEPTOX Study

Spasticity is one of the most disabling symptoms in multiple sclerosis (MS). Botulinum toxin injection (BTI) is a first-line treatment for focal spasticity. There is a lack of evidence of a functional improvement following BTI in MS-related spasticity. To describe goal-setting for BTI in MS, and eva...

Descripción completa

Detalles Bibliográficos
Autores principales: Baccouche, Ines, Bensmail, Djamel, Leblong, Emilie, Fraudet, Bastien, Aymard, Claire, Quintaine, Victorine, Pottier, Sandra, Lansaman, Thibaud, Malot, Claire, Gallien, Philippe, Levy, Jonathan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9504895/
https://www.ncbi.nlm.nih.gov/pubmed/36136520
http://dx.doi.org/10.3390/toxins14090582

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9504895/
https://www.ncbi.nlm.nih.gov/pubmed/36136520
http://dx.doi.org/10.3390/toxins14090582

Ejemplares similares